Bausch Health Companies (BHC) FCF Payout Ratio Growth (1y) (2010 - 2013)
Bausch Health Companies (BHC) FCF Payout Ratio Growth (1y) (2010 - 2013) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | 15.81% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -130.26% |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | 37.82% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.71 Bn | 397.29 Mn | 2.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -100.00% |
| Dec 31, 2012 | 158.22% |
| Dec 31, 2011 | 99.44% |
| Sep 30, 2011 | 26.74% |
| Dec 31, 2010 | -25,345.73% |
| Sep 30, 2010 | -15.17% |
| Jun 30, 2010 | -78.20% |